rabeprazole has been researched along with Esophageal Diseases in 3 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The patient's esophageal ulcer resolved with the aid of dietary changes and a prescription of rabeprazole, a proton pump inhibitor." | 4.84 | Recognizing doxycycline-induced esophageal ulcers in dental practice: a case report and review. ( Segelnick, SL; Weinberg, MA, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Molina-Infante, J | 1 |
| Ferrando-Lamana, L | 1 |
| Vinagre-Rodriguez, G | 1 |
| Hong, SP | 1 |
| Park, PW | 1 |
| Hwang, SG | 1 |
| Ko, KH | 1 |
| Kwak, SY | 1 |
| Kim, SH | 1 |
| Kwon, KS | 1 |
| Shin, YW | 1 |
| Ryu, JK | 1 |
| Ryu, KH | 1 |
| Park, SJ | 1 |
| Won, WH | 1 |
| Yoo, HM | 1 |
| Bae, HM | 1 |
| Park, MJ | 1 |
| Woo, YK | 1 |
| Kim, KC | 1 |
| Kim, KH | 1 |
| Na, SH | 1 |
| Kim, JW | 1 |
| Segelnick, SL | 1 |
| Weinberg, MA | 1 |
1 review available for rabeprazole and Esophageal Diseases
| Article | Year |
|---|---|
Recognizing doxycycline-induced esophageal ulcers in dental practice: a case report and review.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Collagen; | 2008 |
1 trial available for rabeprazole and Esophageal Diseases
| Article | Year |
|---|---|
Significance of non-erosive minimal esophageal lesions in gastro-esophageal reflux disorder.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 2004 |
1 other study available for rabeprazole and Esophageal Diseases
| Article | Year |
|---|---|
Esophageal hyperkeratosis after proton pump inhibitor therapy in a patient with esophageal eosinophilia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Eosinophilic Esophagitis; Esophageal Diseases; Esophagoscop | 2013 |